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Abstract
There is great potential to be explored regarding the use of agent-based modelling and simulation as an alternative
paradigm to investigate early-stage cancer interactions with the immune system. It does not suffer from some limitations of
ordinary differential equation models, such as the lack of stochasticity, representation of individual behaviours rather than
aggregates and individual memory. In this paper we investigate the potential contribution of agent-based modelling and
simulation when contrasted with stochastic versions of ODE models using early-stage cancer examples. We seek answers to
the following questions: (1) Does this new stochastic formulation produce similar results to the agent-based version? (2) Can
these methods be used interchangeably? (3) Do agent-based models outcomes reveal any benefit when compared to the
Gillespie results? To answer these research questions we investigate three well-established mathematical models describing
interactions between tumour cells and immune elements. These case studies were re-conceptualised under an agent-based
perspective and also converted to the Gillespie algorithm formulation. Our interest in this work, therefore, is to establish a
methodological discussion regarding the usability of different simulation approaches, rather than provide further biological
insights into the investigated case studies. Our results show that it is possible to obtain equivalent models that implement
the same mechanisms; however, the incapacity of the Gillespie algorithm to retain individual memory of past events affects
the similarity of some results. Furthermore, the emergent behaviour of ABMS produces extra patters of behaviour in the
system, which was not obtained by the Gillespie algorithm.
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Introduction
In previous work, three case studies using established mathe-
matical models of immune interactions with early-stage cancer
were considered in order to investigate the additional contribution
of ABMS to ODE models simulation [1]. These case studies were
re-conceptualised under an agent-based perspective and the
simulation results were compared with those from the ODE
models. Our results showed that, apart from the well known
differences between these approaches (as those outlined for
example, in Schieritz and Milling [2]), further insight from using
ABMS was obtained, such as extra population patterns of
behaviour.
In this work we apply the Gillespie algorithm [3,4], which is a
variation of the Monte Carlo method, to create stochastic versions
of the original ODE models investigated in [1]. We aim to
reproduce the variability embedded in the ABMS systems to the
mathematical formulation and verify whether results resemble
each other. In addition, due to the fact that the Gillespie algorithm
also regards integer quantities for their elements, we hope that this
method overcomes some differences observed when comparing
atomic agents represented in the ABMS with possible fractions of
elements observable in the ODE results.
To the best of our knowledge, current literature regarding the
direct comparison of the Gillespie algorithm and ABMS is scarce.
We want therefore to answer research questions such as: (1) Does
this new stochastic formulation produce similar results to ABMS?
(2) Can these methods be used interchangeably for our case
studies? (3) Does the stochastic model implemented using the
Gillespie algorithm also find the extra patterns revealed by the
ABMS? We aim to establish a methodological discussion regarding
the benefits of each approach for biological simulation, rather than
provide further insights into the biological aspects of the problems
studied. We therefore intend to compare the dynamics of each
approach and observe the outcomes produced over time. We hope
that this study provides further insights into the potential usability
and contribution of ABMS to systems simulation.
Case Studies
The case studies used for our comparison regard models with
different population sizes, varying modelling effort and model
complexity. We hope that by tackling problems with different
characteristics, a more robust analysis of our experiments is
performed. The features of each case study are shown in Table 1.
The first case study considered is based on an ODE model
involving interactions between generic tumour and effector cells.
The second case study adds to the previous model the influence of
the IL-2 cytokine molecules in the immune responses. The third
case study comprises a model of interactions between effector cells,
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tumour cells, and IL-2 and TGF-b molecules. For all case studies,
three approaches are presented: the original mathematical model,
its conversion into the Gillespie algorithm model and the ABMS
model. To answer our research questions, the Gillespie and ABMS
approaches outcomes are compared. Our results show that for
most cases the Gillespie algorithm does not produce outcomes
statistically similar to the ABMS. In addition, Gillespie is incapable
to reproduce the extreme patterns observed in the ABMS
outcomes for the last case study.
The remainder of this paper is organized as follows. The next
section introduces the literature review comparing stochastic ODE
models and ABMS for different simulation domains. First, we
show general work that has been carried out in areas such as
economics and operations research, and then we focus on research
concerned with the comparison for immunological problems.
Finally, we discuss gaps in the literature regarding cancer research.
In the following section we introduce our Gillespie and agent-
based modelling development processes and the methods used for
conducting the experimentation. Subsequently we present our case
studies, comparison results and discussions. In the final section we
draw our overall conclusions and outline future research
opportunities.
Related Work
Current in-silico approaches used in early-stage cancer research
include computational simulation of compartmental models,
individual-based models and rule-based models. Compartmental
models adopt an aggregate representation of the elements in the
system. They include deterministic methods such as ordinary
differential equation (ODE) models, system dynamics (SD) models
and partial differential equation (PDE) models. These models have
been largely employed in the study of dynamics between cancer
cells and tumour cells [5,6], therapies for cancer [7], tumour
responses to low levels of nutrients [8–11] and tumour vascular-
ization[12,13]. Although these models have been very useful to
understand and uncover various phenomena, they present several
limitations. For instance, they do not encompass emergent
behaviour and stochasticity. In addition, it is difficult to keep a
record of individual behaviour and memory over the simulation
course [14,15]. Stochastic compartmental models include Monte
Carlo simulation models, which are computational algorithms that
perform random sampling to obtain numerical results [16].
Amongst others, they are useful for simulating biological systems,
such as cellular interactions and the dynamics of infectious diseases
[17]. As these methods rely on stochastic process to produce their
outputs, they overcome some of the limitations of the deterministic
compartmental models, as they allow for variability of outcomes.
The individuals in these models, however, do not have any sort of
memory of past events. Rule-based models are a relatively new
research area mostly focused on modelling and simulating
biochemical reactions, molecular interactions and cellular signal-
ling. The literature regarding the application of rule-based models
to interactions between the immune system and cancer cells,
however, is scarce. Individual-based models, or agent-based
modelling and simulation (ABMS), relax the aggregation assump-
tions present in compartmental approaches and allow for the
observation of the behavior of the single cells or molecules
involved in the system. This approach has also been applied to
early-stage cancer research [1,18].
The differences between deterministic compartmental models
and individual-based models are well known in operations
research [2,19–21] and have also been studied in epidemiology
[22,23] and system’s biology [24–26]. Deterministic compartmen-
tal models assume continuous values for the individuals in the
system, whereas in ABMS individual agents are represented. This
peculiarity of each approach highly impacts the simulation results
similarity depending on the size of the populations [1]. There is
still however the need for further investigations between the
interchangeable use of some Monte Carlo methods and ABMS.
Approaches Comparison
As mentioned previously, there are few studies that compare the
Gillespie algorithm with ABMS. Most of these studies regard
Table 1. Case studies considered.
Case Study Number of populations Population size Complexity
1) Tumour/Effector 2 5 to 600 Low
2) Tumour/Efector/IL-2 3 104 Medium
b3) Tumour/Effector/IL-2/TGF- 4 104 High
doi:10.1371/journal.pone.0095150.t001
Table 2. Reactions for case 1.
Phenomenon Reaction equation Rate law (per cell)
Tumour cell birth T?2|T aT
Tumour cell death 2  T?T abT2
Tumour cell death by effector cells TzE?E nTE
Effector proliferation E?2|E;T pTE
gzT
Effector death by fighting tumour TzE?T mTE
Effector death E? dE
Effector supply ?E s
doi:10.1371/journal.pone.0095150.t002
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research in economic models and immunology. To the best of our
knowledge there is no literature regarding the direct comparison of
these methods to early-stage interactions between the immune
system and tumour cells. This section describes relevant researches
in several areas, which provided further insights into the gaps in
the current literature and the research questions addressed in this
paper.
There are a few attempts of re-conceptualizing agent-based
models into simpler stochastic models of complex systems in
economics. For instance, Daniunas et al. [27] start from simple
models with established agent-based versions (which they named
‘‘the model’s microscopic version’’) and try to obtain an equivalent
macroscopic behavior. They consider microscopic and macro-
scopic versions of the herding model proposed by Kirman [28]
and the diffusion of new products, proposed by Bass in [29]. They
conclude that such simple models are easily replicated in a
stochastic environment. In addition, the authors state that for the
economics field, only very general models, such as those studied in
their article, have well established agent-based versions and can be
described by stochastic or ordinary differential equations. How-
ever, as the complexity of the microscopic environment increases,
it becomes challenging to obtain resembling results with stochastic
simulations and further developments need to be pursuit.
Furthermore, the authors debate that the ambiguity present in
the microscopic description in complex systems is an objective obstacle
for quantitative modeling and needs further studying.
Stracquadanio et al. [30] investigate the contributions of ABMS
and the Gillespie method for immune modelling. The authors,
however, do not apply both methods to the same problem.
Instead, for the first approach, they chose to investigate a large-
scale model involving interactions of immune cells and molecules.
This model’s objective was to simulate the immune elements
interplay over time. For the Gillespie approach, the authors
investigate a stochastic viral infection model. The authors point
out three factors that play a major role in the modeling outcome
when comparing ABMS and Gillespie: simulation time, model
precision and accuracy, and model applicability. Regarding time,
the authors state that stochastic models implemented with the
Gillespie algorithm are preferred. On the other hand, ABMS
permits more control over simulation runtime as it keeps record of
the behavior of each single entity involved in the system.
Regarding applicability, the authors argue that traditional
Gillespie methods do not account for spatial information, which
can be detrimental to the model accuracy given the fact that many
immune interactions occur within specific spatial regions of the
simulation environment.
Karkutla [31] compares two biological simulators: GridCell,
which is a stochastic tool based on Gillespie’s, and his new
developed ABMSim, which is a simulation tool based on ABMS.
GridCell was developed to overcome the issues in traditional
Gillespie’s, as pointed out by Stracquadanio et al. [30]. It is a
stochastic tool able to tackle non-homogeneity effectively by
addressing issues of crowding and localization. In GridCell,
however, the problem of tracking individual behaviour and
determining particular characteristics to each element still exists.
ABMSim was therefore developed to overcome these issues.
GridCell has been compared with ABMSim qualitatively and
quantitatively and the two tools have produced similar results in
the author experiments.
In our work we further study the differences between the
approaches outcomes and investigate whether under different
problem characteristics for early-stage cancer we still obtain
Table 3. Agents’ parameters and behaviours for case 1.
Agent Parameters Reactive behaviour Proactive behaviour
Tumour Cell ba and Dies (with age)
ba and Proliferates
m Damages effector cells
n Dies killed by effector cells
Effector Cell m Dies (with age)
d Dies per apoptosis
gp and Proliferates
s Is injected as treatment
doi:10.1371/journal.pone.0095150.t003
Table 4. Transition rates calculations from the mathematical equations for case 1.
Agent Transition Mathematical equation Transition rate
Tumour Cell proliferation aT(1{Tb) a{(TotalTumour:b)
death aT(1{Tb) a{(TotalTumour:b)
dieKilledByEffector nTE n:TotalEffectorCells
causeEffectorDamage mTE m
Effector Cell Reproduce pTE
gzT
p:TotalTumourCells
gzTotalTumourCells
DiePerAge dE d
DiePerApoptosis mTE message from tumour
doi:10.1371/journal.pone.0095150.t004
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similar results. In the next section we introduce the methodology
used to conduct our investigations.
Methods
This section introduces the research methodology used for the
development of our simulation models and for the experimenta-
tion performed in the following sections. As mentioned previously,
our investigations concern the use of three cases to answer
research questions regarding the application of the Gillespie
algorithm and ABMS interchangeably for early-stage cancer
models. For each case study, there is a well established ODE
model from the literature and its correspondent agent-based
model, that we previously developed in [1]. The ODE model
simulations are implemented using the ODE solver module from
MATLAB (2011)
The Gillespie algorithm is implemented by the direct conversion
of the original mathematical equations into reactions and
simulating them under the COPASI 4:8 (Build35) simulator
environment. The method used for the stochastic simulations is the
Gillespie algorithm adapted using the next reaction method [32],
with interval sizes of 0:1, integration interval between 0 and 1 and
maximum internal steps of 106.
ABMS is a modelling and simulation technique that employs
autonomous agents that interact with each other. The agents’
behaviour is described by rules that determines how they learn,
interact and adapt. The overall system behaviour is given by the
agents individual dynamics as well as their interactions. Our agent-
based models are implemented using the AnyLogicTM 6.5
educational version (XJ Technologies 2010) [33]. This approach
is developed by using state charts and tables containing each agent
description. The state charts show the different possible states of an
entity and define the events that cause a transition from one state
to another. In order to facilitate the understanding of the agent-
based model, we reproduce here the models developments, which
were based on [1] (The ABMS and Gillespie models are available
for download in http://anytips.cs.nott.ac.uk/wiki/index.php/
Resources).
Methodology for Results Comparison
As the Gillespie and ABMS are both stochastic simulation
methods, we ran five hundred replications for each case study and
calculated the mean values for the outputs. For all approaches, the
rates (for cellular death, birth, etc.) employed were the same as
those established by the mathematical model.
In addition, in order to investigate any statically significant
differences between the ABMS and Gillespie techniques for the
case studies, we implement a mixed effect model. This is a type of
regression that considers both fixed and random effects. This
method accounts for correlation caused by repeating the measure
over time (i.e., the tumour cell count is correlated over time for
each simulation run). The mixed effect analysis was implemented
in the programming language R using the package NLME [34].
As a mixed effect model requires finding parameters for a
regression model, it is not suitable when considering the whole
time period. This is because in cases 2 and 3 the tumour dynamics
has a damping oscillation and the function describing this
dynamics is unknown (see pages 11 and 14). Instead, the sequence
of local maxima and minima are used. It can been seen that these
are converging and any statistical deviation between these
sequences for the different simulation techniques indicate differ-
ences between the output of the techniques. If the simulations from
the ABMS and the Gillespie technique come from the same
distribution, then there would be no statistical difference between
the maxima and minima over time. Therefore, we investigate two
Figure 1. ABMS state charts for case 1.
doi:10.1371/journal.pone.0095150.g001
Table 5. Simulation parameters for the four different scenarios under investigation.
Scenario b d s
1 0.002 0.1908 0.318
2 0.004 2 0.318
3 0.002 0.3743 0.1181
4 0.002 0.3743 0
For the other parameters, the values are the same in all experiments, i.e. a~1:636, g~20:19, m~0:00311, n~1 and p~1:131.
doi:10.1371/journal.pone.0095150.t005
Gillespie and Agent-Based for Early-stage Cancer
PLOS ONE | www.plosone.org 4 April 2014 | Volume 9 | Issue 4 | e95150
null hypotheses. The first is that the function of local maxima is the
same for the ABMS and the Gillespie algorithm simulations. And
the second is that the function of local minima is the same for the
ABMS and the Gillespie algorithm simulations. We use a 1%
significance level.
There is no standard technique for estimating the required
sample size for non-linear mixed effect models for a defined power
when the measure of effect is known [35]. Therefore, the
simulations are run 500 times as this will increase the statistical
power and increase the probability of a true positive in the
statistical analysis. A false negative is still possible if there is only a
small effect size, but if the effect is small, it is of less interest.
Case 1: Interactions between Tumour Cells and Generic
Effector Cells
The first case considers tumour cells growth and their
interactions with general immune effector cells, as defined in [8].
According to the model, effector cells search and kill the tumour
cells inside the organism. They proliferate proportionally to the
number of existing tumour cells. As the quantities of effector cells
increase, their capacity of eliminating tumour cells is augmented.
Immune cells proliferate and die per apoptosis, which is a
programmed cellular death. In the model, cancer treatment is also
considered and it consists of injections of new effector cells in the
organism.
Mathematically, the interactions between tumour cells and
immune effector cells are defined as follows [8]:
dT
dt
~Tf (T){dT (T ,E) ð1Þ
dE
dt
~pE(T ,E){dE(T ,E)
{aE(E)zW(T)
ð2Þ
where
N T is the number of tumour cells,
N E is the number of effector cells,
N f (T) is the growth of tumour cells,
N dT (T ,E) is the number of tumour cells killed by effector cells,
N pE(T ,E) is the proliferation of effector cells,
N dE(T ,E) is the death of effector cells when fighting tumour
cells,
Figure 2. Results for the first case study.
doi:10.1371/journal.pone.0095150.g002
Table 6. The fixed parameter values returned by the mixed-effect model and their significance.
Method Parameter Value std error p-value
ABS a 0.03393 0.0004397 0
SODE a 0.02925 0.0006126 0
ABS b 41.15847 0.6149638 0
SODE b 52.07957 1.0328222 0
doi:10.1371/journal.pone.0095150.t006
Gillespie and Agent-Based for Early-stage Cancer
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N aE(E) is the death (apoptosis) of effector cells,
N W(T) is the treatment or influx of cells.
The Kuznetsov model [8] defines the functions f (T), dT (T ,E),
pE(E,T), dE(E,T), aE(E) and W(t) as shown below:
f (T)~a(1{bT) ð3Þ
dT (T ,E)~nTE ð4Þ
pE(E,T)~
pTE
gzT
ð5Þ
dE(E,T)~mTE ð6Þ
aE(E)~dE ð7Þ
W(t)~s ð8Þ
Table 2 shows the mathematical equations converted into
reactions and their respective rate laws per cell.
In the agent-based model there are two classes of agents, the
tumor cells and the effector cells, as described in [1]. Table 3
shows the parameters and behaviours corresponding to each agent
state. For our agents, state charts are used to represent the
different states each entity is in. In addition, transitions are used to
indicate how the agents move from one state to another. Events
are also employed and they indicate that certain actions are
scheduled to occur in the course of the simulation, such as
injection of treatment. The state chart representing the tumour
cells is shown in Figure 1(a), in which an agent proliferates, dies
with age or is killed by effector cells. In addition, tumour cells
Table 7. Reactions for case 2.
Name Reaction equation Rate law (per cell)
Effector cell recruitment ?E;T cT
Effector cell proliferation E?2|E; I p1E:IL
(g1zIL )
Effector cell death E? m2E
Effector cell supply ?E s1
Tumour cell birth T?2|T aT
Tumour cell death 2  T?T abT2
Tumour cell death by effector cells TzE?E;T aaTE
g2zT
IL-2 production ?I ;ET p2ET
g3zT
IL-2 decay I? m3
IL-2 supply ?I s2
doi:10.1371/journal.pone.0095150.t007
Table 8. Agents’ parameters and behaviours for case 2.
Agent Parameters Reactive behaviour Proactive behaviour
Effector Cell mu2 Dies
g1p1 and Reproduces
c Is recruited
s1 Is injected as treatment
g3p2 and Produces IL-2
g2aa and Kills tumour cells
Tumour Cell ba and Dies
ba and Proliferates
g2aa and Dies killed by effector cells
c Induces effector recruitment
IL-2 g3p2 and Is produced
mu3 Is lost
s2 Is injected
doi:10.1371/journal.pone.0095150.t008
Gillespie and Agent-Based for Early-stage Cancer
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contribute to damage to effector cells, according to the same rate
as defined by the mathematical model (Table 4). Figure 1(b) shows
the state chart for the effector cells. In the figure, the cell is either
alive or dead by age or apoptosis. While the cell is alive, it is also
able to kill tumour cells and proliferate. In the transition rate
calculations, the variable TotalTumourCells corresponds to the
total number of tumour cell agents; and the variable
TotalEffectorCells is the total number of effector cell agents. In
the simulation model, apart from the agents, there is also an event
– namely, treatment – which produces new effector cells with a
rate defined by the parameter s.
Experimental design for the simulations. Similarly to the
experiments from [1], four scenarios are investigated. The
scenarios have different rates for the death of tumour cells (defined
by parameter b), effector cells apoptosis (defined by parameter d)
and different treatments (parameter s). The values for these
parameters are obtained from [6] (Table 5). In the first three
scenarios, cancer treatment is considered, while the fourth case
does not consider any treatment. The simulations for the ABMS
and the Gillespie algorithm are run five hundred times and the
mean values are displayed as results.
Results and discussion. Figure 2 shows the results of our
experiments. In the first column we display the results from the
ODE model for guidance. The second column shows the results
from the Gillespie algorithm and the third column presents the
ABMS results. Each row of the figure represents a different
scenario.
Results for Scenario 1 appear similar for the three approaches,
although the effector cells curve from the ABMS show more
variability. To evaluate whether the results are significantly
different for the two simulation methods, we apply a mixed effect
model. The null hypothesis is that there is no significant difference
between the methods (and therefore there will be no significant
fixed effect for the method type). We use a 1% significance level.
We are testing the similarity for the population of effector cells.
The effector cells follow a dynamic similar to 1/x for the time
between 1 and 100:
f (t)~
5
a|(tzb)
ð9Þ
We apply a mixed-effect model where the simulation run is
considered to have a random effect on the parameter a and the
simulation method has a fixed effect on a and b. The results are
presented in Table 6. At a 1% significance level the results of the
two techniques are significantly different as the p-values for the
fixed effect of the method on the parameters are less than 0:1.
We believe that the variability observed in the ABMS and
Gillespie curves, given their stochasticity, also influenced the
statistical test results. The number of effector cells for all
simulations follow a similar pattern, although the similarity
hypothesis was rejected. This variability of Gillespie and ABMS
is very evident with regards to the effector cells population as the
size of the populations involved in the first scenario is relatively
small, which increases the impacts of stochasticity in the outcomes.
Results for scenario 2 are shown in the second row of Figure 2.
The outcomes seem fairly different. By observing the ODE results,
during about the first ten days, the tumour cells decrease and then
grow up to a value of about 240 cells, subsequently reaching a
Table 9. Transition rates calculations from the mathematical equations for case 2.
Agent Transition Mathematical equation Transition rate
Effector Cell Reproduce p1 :ILE
g1zIL 2
p1 :TotalIL 2:TotalEffector
g1zTotalIL 2
Die m2E mu2
killTumour aaET
g2zT
aa TotalTumour
g2zTotalTumour
ProduceIL2 p2ET
g3zT
p2:TotalTumour
g3zTotalTumour
Tumour Cell Reproduce aT(1{bT) a{(TotalTumour:b)
Die aT(1{bT) a{(TotalTumour:b)
DieKilledByEffector aaTE
g2zT
message from effector
IL-2 Loss m3IL mu3
doi:10.1371/journal.pone.0095150.t009
Figure 3. ABMS state charts for the agents of case 2.
doi:10.1371/journal.pone.0095150.g003
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steady-state. This initial decrease is also observed in both Gillespie
and ABMS curves. However, only the Gillespie method shows a
similar increase in the numbers of tumour cells when compared to
the ODEs. Similarly to the previous scenario, the Gillespie and
ABMS simulation curves present an erratic behaviour throughout
the simulation days. There is, however, an unexpected decay of
tumour cells over time in the ABMS simulation, which does not
happen in the Gillespie outcome. We believe the difference
observed in the ABMS is due to the the individual characteristics
of the agents and their growth/death rates attributed to their
instantiation. While both ODEs and Gillespie are compartmental
models and therefore they apply the model rates to the cells
population, ABMS on the contrary, employs these rates in an
individual basis. As the death rates of the tumour cells agents are
defined according to the mathematical model, when the tumour
cell population grows, the newborn tumour cells have higher death
probabilities, which leads to a considerable number of cells dying
out. This indicates that the individual behaviour of cells can lead
to a more chaotic behaviour when compared to the aggregate view
observed in the compartmental simulation.
For scenarios 3 and 4, shown in third and fourth rows of
Figure 2, respectively, the results for the three approaches differ
completely. The differences are even more evident for the tumour
cells outcomes. The ODEs results for scenario 3 reveal that
tumour cells decreased as effector cells increased, following a
predator-prey trend curve. For the ABMS, however, the number
of effector cells decreased until a value close to zero was reached,
while the tumour cells numbers were very different from those in
the ODEs results. The ODE pattern noticed was possible given its
continuous character. In the ODE simulation outcome curve for
the effector cells it is therefore possible to observe, for instance,
that after sixty days the number of effector cells ranges between
one and two. These values could not be reflected in the ABMS
simulation, as it deals with integer values. Similarly, the Gillespie
approach outcomes did not resemble those from the ODE model.
There is more variability in the tumour cells curve than in the
ABMS outcomes, although the number of tumour cells also
reaches zero after around sixty days.
In the fourth scenario, although effector cells appear to decay in
a similar trend for both approaches, the results for tumour cells
vary largely. In the ODE simulation, the numbers of effector cells
reached a value close to zero after twenty days and then increased
to a value smaller than one. For the ABMS simulation, however,
these cells reached zero and never increased again. For the
Gillespie model results, a similar pattern as that from the ABMS
model occurs, although there seems to be less variance in the
outcome curve. In addition, the mean numbers for tumour cells
for the Gillespie approach seem smaller that those observed in the
ABMS.
Summary. An outcome comparison between an ABMS and
a Gillespie algorithm model was performed for case study 1. We
considered an ODE model of tumour cells growth and their
interactions with general immune effector cells as the baseline for
results validation. Four scenarios considering small population
numbers were investigated and results from ABMS and Gillespie
were different for both populations for all scenarios. Furthermore,
both approaches differed largely from the original mathematical
outcomes. These results indicate that, for this case study, the
stochasticity applied to the population as a whole when compared
to that applied to the individual has a higher impact given the
small population sizes. The result analysis also reveals that
conceptualizing the stochastic approaches from the mathematical
equations does not always produce statistically similar outputs.
Case 2: Interactions between Tumour Cells, Effector Cells
and Cytokines IL-2
Case two regards the interactions between tumour cells, effector
cells and the cytokine IL-2. It extends the previous study as it
considers IL-2 as molecules mediating the immune response
towards tumour cells. These molecules interfere in the prolifera-
tion of effector cells, which occurs proportionally to the number of
tumour cells in the system. For this case, there are two types of
treatment, the injection of effector cells or the addition of
cytokines.
The mathematical model used in case 2 is obtained from [9].
The model’s equations described bellow illustrate the non-spatial
Table 10. Parameter values for case 2.
Parameter Value
a 0.18
b 0.000000001
c 0.05
aa 1
g2 100000
s1 0
s2 0
mu2 0.03
p1 0.1245
g1 20000000
p2 5
g3 1000
mu3 10
doi:10.1371/journal.pone.0095150.t010
Table 11. The results of the mixed model for the sequence of local maxima in case study 2.
Technique Parameter Value Std Error p-value
ABMS a 0.122 0.00073 0
Gillespie a 0.131 0.00102 0
ABMS b 442.249 1.160664 0
Gillespie b 432.243 1.52861 0
ABMS c 23149.344 23.67208 0
Gillespie c 22694.685 31.88635 0
doi:10.1371/journal.pone.0095150.t011
Gillespie and Agent-Based for Early-stage Cancer
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dynamics between effector cells (E), tumour cells (T) and the
cytokine IL-2 (IL):
dE
dt
~cT{m2E
z
p1EIL
g1zIL
zs1
ð10Þ
Equation 10 describes the rate of change for the effector cell
population E [9]. Effector cells grow based on recruitment (cT )
and proliferation (
p1EIL
g1zIL
). The parameter c represents the
antigenicity of the tumour cells (T) [5,9]. m2 is the death rate of
the effector cells. p1 and g1 are parameters used to calibrate the
recruitment of effector cells and s1 is the treatment that will boost
the number of effector cells.
dT
dt
~a(1{bT){
aaET
g2zT
ð11Þ
Equation 11 describes the changes that occur in the tumour cell
population T over time. The term a(1{bT) represents the logistic
growth of T (a and b are parameters that define how the tumour
cells will grow) and aaET
g2zT
is the number of tumour cells killed by
effector cells. aa and g2 are parameters to adjust the model.
dIL
dt
~
p2ET
g3zT
{m3ILzs2 ð12Þ
The IL-2 population dynamics is described by Equation 12.
p2ET
g3zT
determines IL-2 production using parameters p2 and g3. m3 is the
IL-2 loss. s2 also represents treatment. The treatment is the
injection of IL-2 in the system.
Table 7 shows the mathematical model converted into reactions
for the Gillespie algorithm model. The first column of the table
displays the original mathematical equation, followed by the
equivalent reactions and rate laws in the subsequent columns.
As described in [1], the agents represent the effector cells,
tumour cells and IL-2. Their behaviours are shown in Table 8.
The state charts for each agent type are shown in Figure 3. The
ABMS model rates are the same as those defined in the
mathematical model and are given in Table 9. In the transition
rate calculations, the variable TotalTumour corresponds to the
total number of tumour cell agents, the variable TotalEffector is
the total number of effector cell agents and TotalIL 2 is the total
number of IL-2 agents. In the simulation model, apart from the
agents, there are also two events: the first event adds effector cell
agents according to the parameter s1 and the second one adds IL-
2 agents according to the parameter s2.
Experimental design for the simulation. The experiment
is conducted assuming the same parameters as those of the
mathematical model (Table 10). For the ABMS and the Gillespie
algorithm model, the simulation is run five hundred times and the
average outcome value for these runs is collected. Each run
simulates a period equivalent to six hundred days, following the
same time span used for the numerical simulation of the
mathematical model.
Results and discussion. The results obtained are shown in
Figure 4 for tumour cells (left), effector cells (middle) and IL-2
(right), respectively. As the figure reveals, the results for all
populations are analogous; the growth and decrease of all
populations occur at similar times for all approaches. ABMS has
a little more variability in the results, specially regarding IL-2. We
believe that for this case, the large population sizes (around 104)
Table 12. The results of the mixed model for the sequence of local minima in case study 2.
Technique Parameter Value Std Error p-value
ABMS a 0.080 0.00033 0
Gillespie a 0.088 0.00047 0
ABMS b 462.004 1.12224 0
Gillespie b 444.888 1.46963 0
ABMS c 17118.133 25.43450 0
Gillespie c 17416.363 34.44740 0
doi:10.1371/journal.pone.0095150.t012
Figure 4. Results for the second case study: tumour cells, effector cells and IL-2.
doi:10.1371/journal.pone.0095150.g004
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produce a lower variability in the outcomes of the stochastic
approaches. For statistical comparison, results were contrasted by
applying a non-linear mixed effect model, as shown next.
The local maxima sequence follows a second order polynomial
function of the form:
f (t)~cza(t{b)2 ð13Þ
The local minima sequence follows a second order polynomial
function of the form:
f (t)~c{a  (t{b)2 ð14Þ
For the mixed-effect model, we consider a and b to have fixed
effects based on the type of simulation (e.g., ABMS or Gillespie
algorithm) and a and b to have random effects based on the
individual simulation run. The results of the mixed effect model
Figure 5. Illustration of the regression models fit for the sequences of the local maxima and local minima for the two different
simulation techniques. The Gillespie simulations are plotted in purple with the mixed effect models plotted in blue. The ABMS simulation runs are
plotted in orange with the mixed effect models plotted in red.
doi:10.1371/journal.pone.0095150.g005
Table 13. Reactions for case 3.
Name Equation Rate law (per cell)
Effector cell recruitment ?E;TS c|T
1zc|S
Effector death E? m1|E
Effector proliferation TzE?E;T p|I|E
gzI
 
| p{( q1|S
q2zS
 
Tumour cell growth T?2|T a|T
Tumour cell death 2|T?T aT2
K
Tumour cell death by effector cells TzE?E;T aaTE
g2zT
bTumour growth caused by TGF- T?2|T ;S p2|S|T
g3zS
IL-2 production ?I ;ETS p3|E|T
(g4zT)(1zaS)
IL-2 decay I? m2|I
TGF-b production ?I ;T p4T2
h2zT2
TGF-b decay S? m3|S
doi:10.1371/journal.pone.0095150.t013
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are presented in Tables 11 and 12. It can been seen that there is a
significant difference between the a and b parameter values for the
two different techniques. We therefore reject the null hypotheses
and accept that there is a significance difference between the two
techniques in terms of the sequence of maxima and sequence of
minima, at a 1% significance level. Furthermore, the results show
that the ABMS simulations tend to have larger local maxima and
smaller local minima, which is clear in Figure 5.
Summary. Interactions between tumour cells, effector cells
and the cytokine IL-2 were considered to investigate the potential
differences and similarities of ABMS and Gillespie algorithm
outcomes. Statistical comparison between the Gillespie and the
ABMS results show a significant difference in the outcomes.
Compared to the original ODE model used as validation, ABMS
displayed a little more variability in the results, whereas the
Gillespie algorithm followed mostly the same patterns as those
produced by the ODEs for all populations in the simulation. As for
these simulations a bigger number of individuals was required, it
was also observed that, regarding the use of computational
resources, ABMS was far more time- and memory-consuming
than the Gillespie approach.
Case 3: Interactions between Tumour Cells, Effector Cells,
IL-2 and TGF-b
Case study three comprises interactions between tumour cells
and immune effector cells, as well as the immune-stimulatory and
suppressive cytokines IL-2 and TGF-b [5]. According to the ODE
model developed by Arciero et al. in [5], TGF-b stimulates tumour
growth and suppresses the immune system by inhibiting the
activation of effector cells and reducing tumour antigen expres-
sion.
The mathematical model is described by the differential
equations below:
dE
dt
~
cT
1zcS
{m1E
z
p1EI
g1zI
 
p1{
q1S
q2zS
  ð15Þ
Equation 15 describes the rate of change for the effector cell
population E. According to [5], effector cells are assumed to be recruited
to a tumour site as a direct result of the presence of tumour cells. The
parameter c in cT
1zcS represents the antigenicity of the tumour,
which measures the ability of the immune system to recognize
Table 14. Agents’ parameters and behaviours for case 3.
Agent Parameters Reactive behaviour Proactive behaviour
Effector Cell mu1 Dies
q2p1, g1, q1 and Reproduces
c Is recruited
g2aa and Kills tumour cells
Tumour Cell a Dies
a Proliferates
g2aa and Dies killed by effector cells
p2g3 and Has growth stimulated
tethap4 and bProduces TGF-
c Induces effector recruitment
IL-2 g4alpha, p3 and Is produced
mu2 Is lost
bTGF- tethap4 and Is produced
mu3 Is lost
g3p2 and Stimulates tumour growth
doi:10.1371/journal.pone.0095150.t014
Figure 6. ABMS state charts for the agents of case 3.
doi:10.1371/journal.pone.0095150.g006
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tumour cells. The presence of TGF-b (S) reduces antigen
expression, thereby limiting the level of recruitment, measured
by the inhibitory parameter c. The term m1E represents loss of
effector cells due to cell death. The proliferation term
p1EI
g1zI
 
p1{
q1S
q2zS
 
asserts that effector cell proliferation depends
on the presence of the cytokine IL-2 and is decreased when the
cytokine TGF-b is present. p1 is the maximum rate of effector cell
proliferation in the absence of TGF-b, g1 and q2 are half-
saturation constants, and q1 is the maximum rate of anti-
proliferative effect of TGF-b.
dT
dt
~aT 1{
T
K
 
{
aaET
g2zT
z
p2ST
g3zS
ð16Þ
Equation 16 describes the dynamics of the tumour cell population.
The term aT 1{ T
K
 
represents a logistic growth dynamics with
intrinsic growth rate a and carrying capacity K in the absence of
effector cells and TGF-b. The term aaET
g2zT
is the number of tumour
cells killed by effector cells. The parameter aa measures the
strength of the immune response to tumour cells. The third term
p2ST
g3zS
accounts for the increased growth of tumour cells in the
presence of TGF-b. p2 is the maximum rate of increased
proliferation and g3 is the half-saturation constant, which indicates
a limited response of tumour cells to this growth-stimulatory
cytokine [5].
dI
dt
~
p3ET
(g4zT)(1zaS)
{m2I ð17Þ
Table 15. Transition rates calculations from the mathematical equations for case 3.
Agent Transition Mathematical equation Transition rate
Effector Cell Reproduce p1IE
g1zI
|
p1|TotalIL 2
g1zTotalIL 2
|
p1{
q1S
q2zS
 
p1{
q1|TotalTGFBeta
q2zTotalTGFBeta
 
Die m1E mu1
ProduceIL2 p3TE
(g4zT)(1zalphaS)
p3:TotalTumour
(g4zTotalTumour)(1zalpha:TotalTGF )
KillTumour aaTE
g2zT
aa|TotalTumour|TotalEffector
g2zTotalTumour
Tumour Cell Reproduce
aT 1{
T
1000000000
  
TotalTumour:a 1{
TotalTumour
1000000000
  
Die
aT 1{
T
1000000000
  
TotalTumour:a 1{
TotalTumour
1000000000
  
DieKilledByEffector aa:TE
g2zT
message from effector
ProduceTGF p4T2
teta2zT2
p4:TumourCells
teta2zTumourCells2
EffectorRecruitment cT
1zcS
c
1zgamma:TotaltGF
IL-2 Loss m2I mu2
bTGF- Loss m3S mu3
stimulates
TumourGrowth p2T
g3zS
p2:TotalTGF
g3zTotalTGF
doi:10.1371/journal.pone.0095150.t015
Table 16. Parameter values for case 3.
Parameter Value
a 0.18
aa 1
alpha 0.001
c 0.035
g1 20000000
g2 100000
g3 20000000
g4 1000
gamma 10
mu1 0.03
mu2 10
mu3 10
p1 0.1245
p2 0.27
p3 5
p4 2.84
q1 10
q2 0.1121
theta 1000000
k 10000000000
doi:10.1371/journal.pone.0095150.t016
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The kinetics of IL-2 are described in equation 17. The first term
p3ET
(g4zT)(1zaS)
represents IL-2 production which reaches a maximal
rate of p3 in the presence of effector cells stimulated by their
interaction with the tumour cells. In the absence of TGF-b, this is
a self-limiting process with half-saturation constant g4S [5]. The
presence of TGF-b inhibits IL-2 production, where the parameter
a is a measure of inhibition. Finally, m2I represents the loss of IL-2.
dS
dt
~
p4T
2
h2zT2
{m3S ð18Þ
Equation 18 describes the rate of change of the suppressor
cytokine, TGF-b. According to [5], experimental evidence
suggests that TGF-b is produced in very small amounts when
tumours are small enough to receive ample nutrient from the
surrounding tissue. However, as the tumour population grows
sufficiently large, tumour cells suffer from a lack of oxygen and
begin to produce TGF-b in order to stimulate angiogenesis and to
evade the immune response once tumour growth resumes. This
switch in TGF-b production is modelled by the term
p4T
2
h2zT2
, where
p4 is the maximum rate of TGF-b production and t is the critical
tumour cell population in which the switch occurs. The decay rate
of TGF-b is represented by the term m3S.
Table 13 presents the Gillespie algorithm model used for our
simulations. The model was obtained by converting the ODEs into
reaction equations.
The agents established for the ABMS represent the effector
cells, tumour cells, IL-2 and TGF-b populations, as described in
[1]. The agents’ behaviour is defined in Table 14. The state charts
for each agent type are illustrated in Figure 6.
The ABMS model rates corresponding to the mathematical
model are given in Table 15. In the transition rate calculations, the
variable TotalTumour corresponds to the total number of tumour
cell agents; the variable TotalEffector is the total number of
effector cell agents, TotalIL 2 is the total number of IL-2 agents
and TotalTGFBeta is the total TGF-b agents. This model does
not include events.
Experimental Design for the Simulation
The experiment is conducted assuming the same parameters as
those defined for the mathematical model (Table 16). Similarly to
the previous case studies, for the ABMS and Gillespie models the
simulation is run five hundred times and the average outcome
value for these runs is displayed as result. Each run simulates a
Figure 7. Results for the third case study: mean values of tumour cells, effector cells and IL-2.
doi:10.1371/journal.pone.0095150.g007
Figure 8. Results for the third case study: 50 runs for tumour cells.
doi:10.1371/journal.pone.0095150.g008
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period equivalent to six hundred days, following the time interval
used for the numerical simulation of the mathematical model. The
parameters used for the simulations of all approaches are shown in
Table 16.
Results and discussion. The mean results of 500 runs for
the Gillespie algorithm and the ABMS contrasted with the ODE
model are shown in Figure 7. The left graph in the figure presents
the outcomes for tumour cells; the graph in the middle shows the
outputs for effector cells; the graph on the right shows the mean
IL-2 outcomes (the TGF-b results have some particularities and
therefore are discussed next). The figure shows that both Gillespie
and ABMS do not match properly the original results from the
mathematical model. Additionally, ABMS is far more dissimilar
than what was anticipated. In order to understand why the mean
values were that much different from what was expected, we
plotted fifty individual runs for each approach, as shown in
figures 8, 9, 10 and 11. These runs illustrate the variations
observed in both ABMS (left side of the figures) and Gillespie (right
side of the figures) approaches, due to its stochastic character. In
the figures, the ODE model results were also plotted (dashed black
line) in order to highlight the range of variation produced by the
stochastic approaches. As it can be observed in the figures, both
Gillespie and ABMS outcomes produce various slightly distinct
starting times for the growth of populations. In addition to these
variations, for a few runs the populations in ABMS decreased to
zero, as previously reported in [1]. This behaviour was not
reflected in the Gillespie algorithm results. This indicates that it is
not always possible to replicate similar results within both
approaches.
The use of ABS modelling has therefore led to the discovery of
additional ‘‘rare’’ patterns, which we would have not been able to
derive by using analytical methods or the dynamic Monte Carlo
Figure 9. Results for the third case study: 50 runs for effector cells.
doi:10.1371/journal.pone.0095150.g009
Figure 10. Results for the third case study: 50 runs for IL2 cells.
doi:10.1371/journal.pone.0095150.g010
Gillespie and Agent-Based for Early-stage Cancer
PLOS ONE | www.plosone.org 14 April 2014 | Volume 9 | Issue 4 | e95150
method, i.e. the Gillespie algorithm. These ‘‘extreme cases’’ found
by ABMS suggest that there might be circumstances where the
tumour cells are completely eliminated by the immune system,
without the need of any cancer therapies.
We believe that ABMS when compared to Gillespie produces
extra patterns because of the agents individual behaviour and their
interactions. While ODEs and the Gillespie algorithm always use
the same values for the parameters over the entire population
aggregate, ABMS rates vary with time and number of individuals.
Each agent is likely to have distinct numbers for their probabilities
and therefore have its own memory of past events (Gilespie,
however, does not encompass individual memory for its elements).
The agents individual interactions, which give raise to the overall
behaviour of the system, are also influenced by the scenario
determined by the random numbers used. By running the ABMS
multiple times with different sets of random numbers, the
outcomes vary according to these sets and the emerging
interactions of the agents also produce the rare outcome patterns.
For further statistical comparison of the results that follow the
same pattern of behaviour for ABMS and Gillespie, a mixed-effect
model is used. In 236 of the 500 ABMS simulations the tumour
cell population dies out early in time. The remaining 264 ABMS
simulations (where the tumour cell population does not die out
over the [0,600] time period) is compared with the 500 Gillespie
simulations by a non-linear mixed effect model.
The local maxima sequence follows a second order polynomial
function of the form:
f (t)~40311za(t{b)2 ð19Þ
The local minima sequence follows a second order polynomial
function of the form:
f (t)~a  (t{b)2 ð20Þ
For the mixed-effect model we considered a and b to have fixed
effects based on the type of simulation (e.g., ABMS or Gillespie
algorithm) and a and b to have random effects based on the
individual simulation run. The results of the mixed effect model
are presented in Tables 17 and 18. It can been seen that there is a
significant difference between the a and b parameter values for the
two different techniques. We therefore reject the null hypotheses
and accept that there is a significance difference between the two
techniques in terms of the sequence of maxima and sequence of
minima, at a 1% significance level.
Tables 17–18 and Figure 12 show that the sequence of local
maxima of the ABMS diverge from that of the Gillespie algorithm
over time. In the ABMS the tumour cells tend to increase to a
larger count than the Gillespie algorithm simulations causing the
function of local maxima for the ABMS to be significantly greater
than the Gillespie. A possible explanation for this, as mentioned
previously, is the fact that agents have memory and therefore the
rates (death, proliferation, etc) for a certain cell are determined by
the cells (and their proportions) present in the system at the
moment the cell was created. For the Gillespie algorithm, instead,
the rates are applied globally to the entire population and remain
constant over the simulation course. Consequently, for Gillespie,
the individuals do not keep a record of the previous population
dynamics. This explanation is supported by the observation that
the function describing the sequence of local minima of the ABMS
is significantly lower than the Gillespie algorithm over time, as the
same argument would account for the ABMS simulations reaching
lower levels.
Regarding the TGF-b outcomes, the ODEs results reveal
numbers smaller than one (Figure 11 on the right), which is not
possible to achieve with the ABMS and the Gillespie algorithm.
The simulation results regarding these molecules are therefore
completely different for both stochastic approaches. By observing
the multiple runs graph of ABMS, however, results indicate that
the TGF-b grows at around 100 and 200 days, which resembles
what occurs in the ODE simulation for the first two peaks of TGF-
b concentration. This suggests that ABMS, as opposite to
Gillespie, is capable of capturing some of the behaviours of the
analytical results even when the outputs are different. We believe
that these observations need to be further investigated in order to
determine whether this happens in other case studies. In addition,
it is necessary to investigate in what circumstances and range of
Table 17. The results of the mixed model for the sequence of local maxima in case study 3.
Technique Parameter Value Std Error p-value
ABMS a 0.1354 0.001403 0
Gillespie a 0.2244 0.002242 0
ABMS b 747.8501 2.876438 0
Gillespie b 595.3515 3.338526 0
doi:10.1371/journal.pone.0095150.t017
Table 18. The results of the mixed model for the sequence of local minima in case study 3.
Technique Parameter Value Std Error p-value
ABMS a 0.01325 0.0002059 0
Gillespie a 0.01823 0.0002514 0
ABS b 37.33220 2.1334837 0
Gillespie b 5.93249 2.4013484 0
doi:10.1371/journal.pone.0095150.t018
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values ABMS is still capable to reflect behaviours of numbers
smaller than one agent present in the ODE model.
Summary
The third case study simulations investigated interactions
between effector cells, tumour cells and two types of cytokines,
namely IL-2 and TGF-b. When compared to the original ODE
results, both Gillespie algorithm and ABMS produced more
variability in the outcomes. For each of the five hundred runs, a
slightly different start of population growth was observed. In
addition, ABMS produced extra patterns not observed in the
original mathematical model and in the Gillespie results. These
extra patterns have been reported previously in [1] and with the
present work we wanted to find out whether the Gillespie
algorithm simulation results would be as informative. This
indicates that, for this case study, both methods should not be
employed interchangeably, as some extra possible population
patterns of behaviour might not be uncovered without ABMS. We
believe that these emergent examples occur due to the individual
interactions of the agents and their chaotic character. With these
results, we answer our third research question that it is not possible
in this case to obtain extreme patterns using the Gillespie
algorithm.
Conclusions
In this work, we employed three case studies to investigate
circumstances where we can use ABMS and the Gillespie
algorithm interchangeably. We aimed at reproducing the
variability embedded in the ABMS systems to the mathematical
formulation and verify whether results resemble. Current literature
Figure 11. Results for the third case study: 50 runs for TGF-b. The figure on the right is a zoomed version of the figure in the centre.
doi:10.1371/journal.pone.0095150.g011
Figure 12. Illustration of the regression models fit for the sequences of the local maxima and local minima for the two different
simulation techniques. The Gillespie simulations are plotted in purple with the mixed effect models plotted in blue. The ABMS simulation runs are
plotted in orange with the mixed effect models plotted in red.
doi:10.1371/journal.pone.0095150.g012
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regarding the comparison of the Gillespie algorithm and ABMS is
scarce and we wanted therefore to answer the questions: (1) Does
the Gillespie algorithm produce similar results to ABMS? (2) Can
these two methods be used interchangeably for our case studies?
(3) Does the Gillespie algorithm also find the extra patterns
revealed by the ABMS in the third case study? The case studies
investigated regarded models with different characteristics, such as
population sizes, modelling effort demanded and model complex-
ity.
The first case study involved interactions with general immune
effector cells and tumour cells. Four different scenarios regarding
distinct sets of parameters were investigated and in the first three
scenarios treatment was included. ABMS and Gillespie produced
different results for all scenarios. It appears that two major
characteristics of this model influenced the differences obtained: (1)
The small quantities of individuals considered in the simulations
(especially regarding the effector population size, which was always
smaller than ten) that significantly increased the variability of both
stochastic approaches; and (2) the stochasticity of the Gillespie
algorithm is applied to the aggregates, while in the ABMS there is
individual variability.
Case study 2 referred to the investigation of a scenario
containing interactions between effector cells, cytokines IL-2 and
tumour cells. For this case the Gillespie and ABMS approaches
produced similar outcome curves, which also matched the pattern
of behaviour of the mathematical model used for validation. As
populations sizes had a magnitude of 104 individuals, the erratic
behaviour of both stochastic approaches was no longer evident in
the outcomes. However, although results seemed similar, further
statistical tests reject their similarity hypothesis. It was observed
that, for case 2 in general, ABMS simulation outcome curves tend
to have larger local maxima and smaller local minima.
Case study 3 includes the influence of the cytokine TGF-b in the
interactions between effector cells, cytokines IL-2 and tumour cells
from the previous case. The simulation outcomes for the ABMS
were mostly following the same pattern as those produced by the
Gillespie algorithm, although the results were statistically different.
In addition, Gillespie failed to replicate the alternative outcomes
found by the ABMS. This indicates that for this case study the
ABMS results are more informative, as they illustrate another set
of possible dynamics to be validated in real-world. Furthermore,
ABMS was also able to indicate two peaks where TGF-b
concentrations have grown, although the corresponding values
in the mathematical model were smaller than one.
In response to our research questions, we conclude that
regarding the interchangeable use of Gillespie and ABMS,
population size has a positive impact on result similarity. This
means that bigger populations tend to result in close simulation
output patterns. However, the stochasticity of both approaches
and the memory present in the ABMS produce outcome
differences which are statistically significant, although visually
the outcomes look similar. Finally, the emergent behaviour of
ABMS can contribute additional insight (extra patterns), which
was not obtained by the aggregate stochasticity present in
Gillespie, given its incapacity of retaining memory of past events
for their elements.
Currently, it is acknowledged that the necessary levels of detail
present a system’s conceptual model might require the adoption of
multiple simulation approaches, under different scales of abstrac-
tion, in order to produce satisfactory outcomes. For certain cases,
multi-scale and multi-modelling solutions represent the only
possible manner to properly implement a set of requirements,
even though these practices are generally more resource-intensive.
Several models, especially those regarding biological systems,
encompass elements with distinct time and length scales coupled
together. Multiple layers involving different levels of granularity
need therefore to be considered. Phenomena such as cellular
gradient-based chemotaxis and nutrient-dependent cell cycles are
better implemented by employing numerical simulation (such as
partial and ordinary differential equations). On the other hand,
cellular random movement, memory, adaptability, explicit repre-
sentation of space, heterogeneous populations, etc. represent
suitable concepts to be represented within an agent-based
approach. There are also subsets of characteristics in a system
that can be implemented under more than one approach.
Despite of the well-known domains of applicability of each
simulation technique, other factors such as the real-world data
availability, the computing resources, the required granularity of
the model, the time available to develop the simulation, the
research questions and the expertise of the simulation developer
also influence the decision on the paradigms to be adopted. By
understanding the strengths and weaknesses of each approach, it is
possible decide on which route to take and also the implications of
this decision to the final outcome. We hope that our study results
can assist simulation researchers on this debate.
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